Alibaba Group Holding Ltd: Form 20-F for the period ended Mar 31, 2025
Filed with the SEC on Jun 26, 2025 and accepted by EDGAR at Jun 26, 2025, 06:31 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-04-01 to 2025-03-31 | $137.30bn | us-gaap:Revenues |
| Cost of revenue | 12 months2024-04-01 to 2025-03-31 | $82.45bn | us-gaap:CostOfRevenue |
| Research and development | 12 months2024-04-01 to 2025-03-31 | $7.88bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2024-04-01 to 2025-03-31 | $19.42bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2024-04-01 to 2025-03-31 | $1.32bn | us-gaap:InterestExpense |
| Income tax | 12 months2024-04-01 to 2025-03-31 | $4.88bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-04-01 to 2025-03-31 | $17.93bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-04-01 to 2025-03-31 | $0.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-04-01 to 2025-03-31 | $0.95 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-04-01 to 2025-03-31 | 19,318,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-04-01 to 2025-03-31 | $22.53bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2024-04-01 to 2025-03-31 | $4.01bn | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2024-04-01 to 2025-03-31 | $11.94bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-31 | $20.05bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $92.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $248.63bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $59.99bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $98.41bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $139.16bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-03-31 | 18,474,235,708 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-25-090161. Last ingested by Listed: Nov 5, 2026, 11:20 ET. Listed shows no prices and gives no investment advice.